Oxandrolone
Oxandrolone (Anavar, Oxandrin): why FDA withdrew approval in 2023, legal status and known risks.
Approval withdrawn 2023, Schedule III · Evidence grade C · Reviewed
Oxandrolone (Anavar, Oxandrin). Oral anabolic steroid.
CApproval withdrawn 2023, Schedule III. Evidence grade C: limited, early or dated human data.
What is Oxandrolone?
Oxandrolone is an oral anabolic steroid that was prescribed to help regain weight after surgery, chronic infection or severe trauma.
Is Oxandrolone legal and FDA-approved?
FDA withdrew approval of Oxandrin and its generics on June 28, 2023, and later determined the product had been withdrawn for reasons of safety or effectiveness. No approved oxandrolone product is sold in the United States now. It remains a Schedule III controlled substance.
What does the evidence show for Oxandrolone?
Human data from its years as an approved drug at medical doses.
What are the known risks of Oxandrolone?
The product label warned of serious liver problems, including blood-filled cysts in the liver. Anabolic steroids can cause mood and behavior changes and psychological dependence. They suppress natural testosterone and fertility, and are linked to heart, liver and hormonal harm. Non-medical users often take 10 to 100 times the medical dose, which raises every risk. They are banned in sport.
How is Oxandrolone measured?
A tablet, so there is nothing to draw or calculate.
Sources: Federal Register: withdrawal of approval of Oxandrin; Federal Register: Oxandrin withdrawn for safety or effectiveness. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.